Skip to Content

Molson Coors Beverage Co Shs -B- Non-Voting TAP

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

Molson Coors Shows Slow but Steady Progress in Q2, but Market Impatient; Shares Undervalued

Analyst Note

| Nicholas Johnson, CFA |

After a few months in the shadows, the bears were out frolicking once again heading into no-moat Molson Coors’ second-quarter earnings release, as the shares were under pressure after hitting 52-week highs in June. The dour backdrop was apparently due to recent syndicated data showing a slowdown in the domestic beer category (most notably the hard seltzer enclave). Ultimately, even when accounting for the very weak comp due to last year’s pandemic trough, the results were solid and ahead of FactSet consensus on both the top and bottom lines. We don’t plan to change our $64 fair value estimate: time value and better-than-expected hedging benefits to gross margins thus far this year will be offset by higher taxes, as we incorporate Morningstar’s probability-weighted view of an increase in the U.S. statutory rate to 26%. While the road to a leaner operation and secularly advantaged portfolio will remain choppy, we continue to believe the brewer is on the right track. Given the recent sell-off, the shares look cheap, and we think this is a compelling entry point for prospective investors.

Read Full Analysis

Company Profile

Business Description

Molson Coors is the fifth- largest beer producer globally, boasting top-two positioning in the U.S., Canada, and many Central European markets. It brews and markets a slew of company-owned brands including Blue Moon, Coors, Miller, Vizzy, and Staropramen. It also sells various partner brands in certain locales such as Topo Chico (licensed from Coca-Cola), Amstel and Dos Equis in Canada (through an exclusive import/license arrangement with Heineken) and Corona in Central Europe (through an agreement with Anheuser-Busch InBev). The firm's go-to-market approach differs by geography as well, primarily using independent distributors in the U.S., but deploying hybrid models in Canada and Europe.

Contact
NH353, P.O. Box 4030
Golden, CO, 80401
T +1 303 279-6565
Sector Consumer Defensive
Industry Beverages - Brewers
Most Recent Earnings Jun 30, 2021
Fiscal Year End Dec 31, 2021
Stock Type Slow Growth
Employees 17,000

Related

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.